Umavida Pharma Private Limited, a active private limited company, was established on 20 March 2019 in Kadi, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299GJ2019PTC107172. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 70 professional, Its leadership includes Jagdishbhai Bhagwatbhai Desai (Director), Fenil Jitendrakumar Shah (Director), Bindiya Rakesh Gohel (Director). Past directors included Bindiya Rakesh Gohel, Aziz Fidaali Rahemani. It holds ₹40.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Survey No.-396, Opp. Knack Packaging, Kadi-Thol Road, Borisna, Kadi, Gujarat, 382715.
U24299GJ2019PTC107172
107172
20 March 2019
₹0.50 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Umavida Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagdishbhai Bhagwatbhai Desai | Director | 20 Mar 2019 | Current |
| Fenil Jitendrakumar Shah | Director | 20 Mar 2019 | Current |
| Bindiya Rakesh Gohel | Director | 03 Aug 2022 | Current |
| Shil Jitendra Shah | Director | 20 Mar 2019 | Current |
| Varun Hasmukh Patel | Director | 20 Mar 2019 | Current |
| Vipul Raghunath Chaudhari | Director | 20 Mar 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Umavida Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 126456.74% increase. The company also saw a substantial improvement in profitability, with a 8252.96% increase in profit. The company's net worth Soared by an impressive increase of 19396.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Umavida Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹400,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Feb 2022 | Hdfc Bank Limited | ₹20.00 Cr | Open |
| 04 Feb 2022 | Hdfc Bank Limited | ₹20.00 Cr | Open |
Explore comprehensive loan charge details -
Umavida Pharma has a workforce of 70 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Umavida Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umavida Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Umavida Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Umavida Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Bindiya Rakesh Gohel was appointed as a Director was appointed as a Director on 03 Aug 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 200.00 M with Charge ID 100544079 was registered on 17 Feb 2022. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 200.00 M with Charge ID 100545053 was registered on 04 Feb 2022. was recorded as a recent event.
Jagdishbhai Bhagwatbhai Desai was appointed as a Director was appointed as a Director on 20 Mar 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.
The CIN of Umavida Pharma Private Limited is U24299GJ2019PTC107172.
Umavida Pharma Private Limited is headquartered at Survey No.-396, Opp. Knack Packaging, Kadi-Thol Road, Borisna, Kadi, Gujarat, 382715.
Umavida Pharma Private Limited was incorporated on 20 March 2019.
The current directors of Umavida Pharma Private Limited are
The primary industry of Umavida Pharma Private Limited is Manufacturing.
Umavida Pharma Private Limited is unlisted.
The authorized capital of Umavida Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Umavida Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX